RESEARCH GROUPS

New Technologies and Craniofacial Microsurgery

Group page

Number of publications

14.29

% Q1

0.00

% D1

42.86

% Leadership

100.00

% Female Leadership

2.92

CROWN (2021-2025)

37.50

HCP10% (2021-2025)

42.86

% Open access

42.86

% International Collaboration

Highly cited papers / HCP 1% (2021-2025)

Publications in high-IF journals with high Altmetric scores

Number of Ongoing Projectes (total)

International ongoing projects

Number of New projects (total)

International new projects

Number of Active clinical Trials

Number of New Clinical Trials

Number of Theses

Our 3D hub for Oral and Maxillofacial is now our go-to platform to plan and perform our surgeries. We routinely use 3D-planning, navigation, computer-assisted design (CAD) and manufacturing (CAM) techniques to create custom-made prostheses that adapt to each patient’s individual needs. Besides, we use the intraoperative scanner Loop-X for intraoperatively acquired image-guided surgery, a key tool that helps us ensure that surgery has been performed according to plan. This significantly reduces the need for further surgeries later, which is extremely helpful for the patient and an asset to our Hospital as well. Competitive funds were obtained to develop a project in the context of the Spanish multi-center collaboration for the diagnosis, treatment and follow-up of patients with Fanconi Anemia and oral diseases. In our cancer research line, we have continued our collaboration in several clinical trials led by the VHIO.

CORE/MISSIONS

PROGRAMS

TEAM

Group Leader

María Socorro (Coro) Bescós Atín

Researchers

Jorge Pamias Romero, Montserrat Munill Ferrer, Alba de Pablo García-Cuenca, Manel Sáez Barba, Vicenç Juan Gómez, Iago Álvarez Sáez, Adriana Agell Sogbe

PhD Students

Pablo Vaquero Martínez, Ingrid Guarro Marzoa, Pau Rofín Fontanet, Álvaro Bretons

SELECTED PUBLICATIONS

Campos AM, Barba MS, de Pablo García-Cuenca A, Pamias-Romero J, Roca-Bielsa I, Alberola-Ferranti M, Bescós-Atín C.
Relevance of Sentinel Nodes in Atypical Territories in Surgically Treated Patients With T1-2N0 Oral Squamous Cell Carcinoma.
Head Neck. 2025 May;47(5):1471-1477
DOI: 10.1002/hed.28067
IF: 2.2

de Pablo García-Cuenca A, Rofín-Fontanet P, Lorente-Guerrero J, Balmaña-Gelpí J, Carrasco-López E, Temprana-Salvador J, Granado-Carrasco R, Braña-García I, Vaquero-Martínez P, Pujol-Pina R, Bescós-Atín C.
Head and Neck Cancer in Fanconi Anemia: Report of 11 Cases and a Systematic Review.
Cancers (Basel). 2025 Jan 22;17(3):349.
DOI: 10.3390/cancers17030349
IF: 4.4

van Roey VL, Ombashi S, Mathijssen IMJ, Munkhammar ÅA, Åsten PM, Bouzariouh A, Célérier C, Dana C, van Dooren M, Faasse M, Fauroux B, Frykholm P, Heinen A, Heliövaara A, Joosten KFM, Kljajic M, Larsson E, Loudon S, Marinac I, Munill Ferrer M, Poldermans H, Stattin EL, Streppel M, Svensson M, Thierry B, Tjoa STH, Topa A, Weissbach E, Wolvius EB, Zafra Vallejo V, Versnel SL.
The Development of a European Registry for Facial Dysostosis Syndromes: A Delphi-Guided Approach.
J Craniofac Surg. 2025 Nov-Dec 01;36(8):2712-2716.
DOI: 10.1097/SCS.0000000000011695
IF: 1.0

Heredero S, Gómez VJ, Sanjuan-Sanjuan A.
The Role of Virtual Reality, Augmented Reality and Mixed Reality in Modernizing Free Flap Reconstruction Techniques.
Oral Maxillofac Surg Clin North Am. 2025 Aug;37(3):479-486.
DOI: 10.1016/j.coms.2025.04.004. Epub 2025 May 19.
IF: 1.3

Houkes RP, Hens G, Kubon C, Heliövaara A, Dávidovics K, Akota I, Lux S, Ruiz J, Munill M, Redondo Alamillos M, Malet Contreras A, Breugem C.
Learnability of the LAHSHAL Classification for Oral Clefts: Results of an International Webinar.
J Craniofac Surg. 2025 Nov-Dec 01;36(8):3032-3035.
DOI: 10.1097/SCS.0000000000011355.
IF: 1.0

SELECTED PROJECTS

INTERCEPT (INTercEption of oRal CancEr development) COST Action – Addressing the challenge of unmet oral cancer prevention and bringing new paradigm to disease management of oral potentially malignant disorders (OPMD).
Principal Investigator: Coro Bescós (Associate Investigator)
Agency: European Cooperation in Science and Technology (COST Action - EU)
Funding: N/A
Period: 2022-2025

Screening mediante citología de lesiones orales en pacientes con Anemia de Fanconi (AF)
Principal Investigator: Alba de Pablo García-Cuenca
Agency: Fundación Anemia de Fanconi (FAF)
Funding: 100,000 €
Period: 2025 - ongoing

METWASTE2: How Metastatic Tumours Drive Energy Wasting Syndrome – H&N Tumours
Principal Investigator: Coro Bescós
Agency: -
Funding: TBD
Period: TBD

PATENTS

DISSEMINATION ACTIVITIES